UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026378
Receipt number R000030273
Scientific Title Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias
Date of disclosure of the study information 2017/03/03
Last modified on 2018/05/09 16:52:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias

Acronym

Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias

Scientific Title

Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias

Scientific Title:Acronym

Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias

Region

Japan


Condition

Condition

Fetal tachyarrythmia (Supraventricular tachycardia, Atrial flutter)

Classification by specialty

Cardiology Obstetrics and Gynecology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To estimate the efficacy and safety of transplacental anti-arrythmic treatment for fetal tachyarrythmias

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

disappearance of fetal tachyarrythmias in more than half of 30min fetal echocardiogram and/or 40min cardiotocogram

Key secondary outcomes

1 Intrauterine Fetal Death
2 Rate of preterm birth
3 Rate of cesarean section
4 Improvement of fetal heart rate and/or fetal hydrops
5 Neonatal arrythmias
6 CNS findings in neonate
7 Survival rate at 1 month
8 Tachyarrythmias at 1 month


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

These anti-arrythmic agent are administered to pregnant women as treatment for fetal supraventricular tachycardia with short VA interval or atrial flutter. Administration is started with 2nd for fetal hydrops. If the administration of digoxin is ineffective, digoxin is possible to be discontinued.
1st. digoxin
2nd. digoxin and sotalol
3rd. digoxin and flecainide
These anti-arrythmic agent are administered to pregnant women as treatment for fetal supraventricular tachycardia with long VA interval.
1st. sotalol
2nd. flecainide

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 sustained fetal tachyarrythmias
2 gestational age 22w0d~36w6d
3 singleton
4 Informed consent has been obtained from patient

Key exclusion criteria

1 it is impossible to obtain informed consent due to the mental problem
2 the treatment causes serious risk for mother's health
3 Doctor judged inappropriate for the treatment

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Maki Inoue

Organization

Gunma University Hospital

Division name

Department of Obstetrics and Gynecology

Zip code


Address

Maebashi, Gunma

TEL

+81-27-220-8429

Email

m-inoue@gunma-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Maki Inoue

Organization

Gunma University Hospital

Division name

Department of Obstetrics and Gynecology

Zip code


Address

Maebashi, Gunma

TEL

+81-27-220-8429

Homepage URL


Email

m-inoue@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University Hospital

Institute

Department

Personal name



Funding Source

Organization

Gunma University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

群馬大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 02 Month 22 Day

Date of IRB


Anticipated trial start date

2017 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 03 Month 03 Day

Last modified on

2018 Year 05 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030273


Research Plan
Registered date File name
2018/05/07 胎児不整脈 介入研究実施作成指針3 2017年4月.doc

Research case data specifications
Registered date File name
2018/05/09 胎児頻脈性不整脈 新生児CRF.xls

Research case data
Registered date File name
2018/05/09 胎児頻脈性不整脈 新生児CRF.xls